Results 171 to 180 of about 2,224,916 (342)

Adoption of international good manufacturing practices in the Nigerian pharmaceutical industry: promising results from a decade of investment. [PDF]

open access: yesJ Pharm Policy Pract
Adeyeye M   +12 more
europepmc   +1 more source

Insurance and Incentives for Medical Innovation [PDF]

open access: yes
This paper studies the interactions between health insurance and the incentives for innovation. Although we focus on pharmaceutical innovation, our discussion applies to other industries producing novel technologies for sale in markets with subsidized ...
Alan M. Garber   +2 more
core  

Heterogeneity of Rheumatoid Arthritis–Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations With Disease Outcomes

open access: yesArthritis Care &Research, EarlyView.
Objective We aimed to identify unique disease trajectories within rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes. Methods We performed a cohort study of RA‐ILD within the Veterans Health Administration from 1999 to 2021.
Bryant R. England   +9 more
wiley   +1 more source

Intellectual Property and Public Health: An Overview of the Debate with a Focus on U.S. Policy [PDF]

open access: yes
Over the past fifteen years, the United States and other developed countries have employed trade agreements to substantially strengthen the protection of intellectual property rights for pharmaceutical products in the developing world.
Carsten Fink
core   +1 more source

Long‐Term Opioids in Gout: A Matched Cohort Study From the Veterans Health Administration

open access: yesArthritis Care &Research, EarlyView.
Objective Though used frequently to treat flare, risk of long‐term opioid exposure in gout has not been well defined. In this study, we examined the hypothesis that people with gout are more likely than individuals without gout to be prescribed long‐term opioids over time.
Lindsay N. Helget   +7 more
wiley   +1 more source

A study on influencers of total sales revenue of generic pharmaceutical companies in Indonesia [PDF]

open access: yes
This paper empirically examines the influence of firms’ one-year lagged of total new products (t-1), one-year lagged profitability (t-1), and market share of new products to firms’ amount of sales revenue in pharmaceutical generic companies in Indonesia.
Simanjuntak, Destrina Grace   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy